The Association Between Treatment Failure of Bacterial Vaginosis with Metronidazole and the Incidence of the Maternal–Perinatal Composite Index
DOI:
https://doi.org/10.22225/wmj.11.1.13975.17-21Keywords:
Pregnant Women, Bacterial vaginosis , Composite Index, MetronidazoleAbstract
There is high incidence of Bacterial vaginosis (BV) in pregnancy and increasing rate of treatment failure with metronidazole, the drug of choise in BV in pregnancy. The occurrence of bacterial vaginosis in pregnancy results in morbidity and complications for both the mother and the fetus, especially in untreated cases or cases of treatment failure. This study aims to determine the association between treatment failure and the incidence of the maternal–perinatal composite index (preterm labour, PPROM, low birth weight ). This is a cohort study, conducted at Sanjiwani Hospital, Gianyar, from September 2024 to April 2025. involving 52 pregnant less than 20 weeks diagnosed with BV who received metronidazole therapy, divided into two groups, 26 pregnant woman with successful treatment and 26 pregnant woman with treatment failure.The results demonstrated that pregnant women with treatment failure of bacterial vaginosis had a 5.33-fold higher risk of maternal–perinatal complications (OR 5.33; 95% CI = 1.008–28.209; p = 0.049) compared to those with successful treatment.
References
1. Tesfay G, Deekonda K, Paramasivam R, Muthupandian S. Prevalence and associated risk factors of bacterial vaginosis among pregnant women in Africa: a systematic review ; 2020.
2. Pasaribu LR, Dyah SL, Sunarno, Faika, Roselinda. Prevalensi infeksi saluran reproduksi dan HIV pada wanita hamil di beberapa kota di Indonesia (Laporan Penelitian). Kementerian Kesehatan; 2016.
3. Wiraguna AAGP, Rusyati LMM, Vijayamurthy IDAV. Bacterial vaginosis as a risk factor of preterm premature rupture of membrane (PPROM). Bali Dermatol Venereol Aesthetic J. 2018 Dec 14;1(2):36–9.
4. Arif F. Bacterial vaginosis: risk of adverse pregnancy outcome. J Gynecol Res Obstet. 2018 Jun 20;4(1):15–7.
5. Dingens AS, Fairfortune TS, Reed S, Mitchell C. Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth. 2016 Dec 22;16(1):278.
6. Nelson DB, Macones G. Bacterial vaginosis in pregnancy: current findings and future directions. Epidemiol Rev. 2002 Dec 1;24(2):102–8.
7. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol. 2004 Oct;191(4):1124–9.
8. Cauci S, Culhane JF, Di Santolo M, McCollum K. Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1?. Am J Obstet Gynecol. 2008 Jan;198(1):132.e1-132.e7.
9. Eschenbach DA. Bacterial vaginosis: resistance, recurrence, and/or reinfection? Clin Infect Dis. 2007 Jan 15;44(2):220–1.
10. Muzny CA, Schwebke JR. Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections: Table 1. Clin Infect Dis. 2015 Aug 15;61(4):601–6.
11. Jones A. Bacterial vaginosis: a review of treatment, recurrence, and disparities. J Nurse Pract. 2019 Jun;15(6):420–3.
12. Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis. Curr Opin Infect Dis. 2013 Feb;26(1):86–9.
13. Aduloju OP, Akintayo AA, Aduloju T. Prevalence of bacterial vaginosis in pregnancy in a tertiary health institution, south western Nigeria. Pan Afr Med J. 2019;33:9.
14. Mulinganya G, De Vulder A, Bisimwa G, Boelens J, Claeys G, De Keyser K, et al. Prevalence, risk factors and adverse pregnancy outcomes of second trimester bacterial vaginosis among pregnant women in Bukavu, Democratic Republic of the Congo. PLoS One. 2021 Oct 25;16(10):e0257939.
15. Ng BK, Chuah JN, Cheah FC, Mohamed Ismail NA, Tan GC, Wong KK, et al. Maternal and fetal outcomes of pregnant women with bacterial vaginosis. Front Surg. 2023 Feb 13;10:1062332.
16. Prodan-Barbulescu C, Bratosin F, Folescu R, Boeriu E, Popa ZL, Citu C, et al. Analysis of vaginal microbiota variations in the third trimester of pregnancy and their correlation with preterm birth: a case-control study. Microorganisms. 2024 Feb 19;12(2):417.
17. Machado A, Cerca N. Influence of biofilm formation by Gardnerella vaginalis and other anaerobes on bacterial vaginosis. J Infect Dis. 2015 Dec 15;212(12):1856–61.
18. Klebanoff MA, Schuit E, Lamont RF, Larsson P, Odendaal HJ, Ugwumadu A, et al. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: Systematic review and individual participant data meta?analysis. Paediatr Perinat Epidemiol. 2023 Mar 18;37(3):239–51.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Kennedy Winartan, I Gusti Ayu Sri Anjani, Anak Agung Raka Budayasa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
